These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34638258)

  • 21. Liquid Biopsy in Prostate Cancer Management-Current Challenges and Future Perspectives.
    Crocetto F; Russo G; Di Zazzo E; Pisapia P; Mirto BF; Palmieri A; Pepe F; Bellevicine C; Russo A; La Civita E; Terracciano D; Malapelle U; Troncone G; Barone B
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precision medicine for advanced prostate cancer.
    Mullane SA; Van Allen EM
    Curr Opin Urol; 2016 May; 26(3):231-9. PubMed ID: 26909474
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Homologous recombination repair deficiency as a predictive biomarker : Basic mechanisms and detection methods].
    Pfarr N; Merkelbach-Bruse S
    Pathologe; 2021 Jul; 42(4):391-398. PubMed ID: 34152463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancer.
    Kohli M; Tan W; Zheng T; Wang A; Montesinos C; Wong C; Du P; Jia S; Yadav S; Horvath LG; Mahon KL; Kwan EM; Fettke H; Yu J; Azad AA
    EBioMedicine; 2020 Apr; 54():102728. PubMed ID: 32268276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular tumor board prostate cancer].
    Seitz AK; Heck MM; Kamer MW; Grüllich C
    Urologe A; 2019 Jul; 58(7):752-759. PubMed ID: 31049637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer.
    Khaddour K; Felipe Fernandez M; Khabibov M; Garifullin A; Dressler D; Topchu I; Patel JD; Weinberg F; Boumber Y
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?
    Miyamoto DT; Lee RJ
    Urol Oncol; 2016 Nov; 34(11):490-501. PubMed ID: 27771279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homologous Recombination Repair Deficiency: An Overview for Pathologists.
    Doig KD; Fellowes AP; Fox SB
    Mod Pathol; 2023 Mar; 36(3):100049. PubMed ID: 36788098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate Cancer.
    Annala M; Struss WJ; Warner EW; Beja K; Vandekerkhove G; Wong A; Khalaf D; Seppälä IL; So A; Lo G; Aggarwal R; Small EJ; Nykter M; Gleave ME; Chi KN; Wyatt AW
    Eur Urol; 2017 Jul; 72(1):34-42. PubMed ID: 28259476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and Cons.
    Tan CR; Zhou L; El-Deiry WS
    Curr Colorectal Cancer Rep; 2016 Jun; 12(3):151-161. PubMed ID: 27516729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration.
    Cui X; Yu H; Yao J; Li J; Li Z; Jiang Z
    BMC Cancer; 2022 Dec; 22(1):1350. PubMed ID: 36564767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.
    Gui B; Gui F; Takai T; Feng C; Bai X; Fazli L; Dong X; Liu S; Zhang X; Zhang W; Kibel AS; Jia L
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14573-14582. PubMed ID: 31266892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA-Damage-Repair Gene Alterations in Genitourinary Malignancies.
    Dariane C; Timsit MO
    Eur Surg Res; 2022; 63(4):155-164. PubMed ID: 35944490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.
    Farmanbar A; Firouzi S; Kneller R; Khiabanian H
    J Transl Med; 2022 Feb; 20(1):65. PubMed ID: 35109853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mismatch repair deficiency and clinical implications in prostate cancer.
    Graham LS; Schweizer MT
    Prostate; 2022 Aug; 82 Suppl 1():S37-S44. PubMed ID: 35358351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging Biomarker-Guided Therapies in Prostate Cancer.
    Deluce JE; Cardenas L; Lalani AK; Maleki Vareki S; Fernandes R
    Curr Oncol; 2022 Jul; 29(7):5054-5076. PubMed ID: 35877260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Total, PTEN
    Di Lorenzo G; Zappavigna S; Crocetto F; Giuliano M; Ribera D; Morra R; Scafuri L; Verde A; Bruzzese D; Iaccarino S; Costabile F; Onofrio L; Viggiani M; Palmieri A; De Placido P; Marretta AL; Pietroluongo E; Luce A; Abate M; Navaeiseddighi Z; Caputo VF; Celentano G; Longo N; Ferro M; Morelli F; Facchini G; Caraglia M; De Placido S; Buonerba C
    Clin Genitourin Cancer; 2021 Oct; 19(5):e286-e298. PubMed ID: 33958297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNA.
    Ritch E; Wyatt AW
    Urol Oncol; 2018 Aug; 36(8):380-384. PubMed ID: 29248429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer.
    Tolkach Y; Kremer A; Lotz G; Schmid M; Mayr T; Förster S; Garbe S; Hosni S; Cronauer MV; Kocsmár I; Kocsmár É; Riesz P; Alajati A; Ritter M; Ellinger J; Ohlmann CH; Kristiansen G
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.